---
title: "小米集團：全球 MIUI 月活躍用户規模再創歷史新高。2023 年 9 月，全球 MIUI 月活躍用户數達到 623.1 百萬，同比增長 10.5%。"
description: "小米集團：全球 MIUI 月活躍用户規模再創歷史新高。2023 年 9 月，全球 MIUI 月活躍用户數達到 623.1 百萬，同比增長 10.5%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/102793396.md"
published_at: "2023-11-20T09:51:44.000Z"
---

# 小米集團：全球 MIUI 月活躍用户規模再創歷史新高。2023 年 9 月，全球 MIUI 月活躍用户數達到 623.1 百萬，同比增長 10.5%。

小米集團 (01810.HK)：全球 MIUI 月活躍用户規模再創歷史新高。2023 年 9 月，全球 MIUI 月活躍用户數達到 623.1 百萬，同比增長 10.5%。

### Related Stocks

- [81810.HK - 小米集團-WR](https://longbridge.com/zh-HK/quote/81810.HK.md)
- [01810.HK - 小米集團-W](https://longbridge.com/zh-HK/quote/01810.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Xiaomi's electric SUV tops China sales in January, sells twice as many as Tesla's Model Y | Xiaomi's YU7 electric SUV topped sales in China in January, selling 37,869 units, double that of Tesla's Model Y, which  | [Link](https://longbridge.com/zh-HK/news/275839815.md) |
| Codeifai Enters AI-Backed Quantum Security Market | Codeifai Ltd :CODEIFAI ENTERS AI-BACKED QUANTUM SECURITY MARKETCOMPLETION OF ACQUISITION OF ANTENNATRANSFER.IOTOTAL CONS | [Link](https://longbridge.com/zh-HK/news/276015719.md) |
| Mediterranean Tourism Investment FY Profit 1.6 Million Dinars | MEDITERRANEAN TOURISM INVESTMENT COMPANY PSC (MDTR.AM):MEDITERRANEAN TOURISM INVESTMENT FY NET PROFIT ATTRIBUTABLE 1.6 M | [Link](https://longbridge.com/zh-HK/news/275999518.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/zh-HK/news/276016059.md) |
| Elon Musk Says Tesla Will Have 'Largest Fleet' Of Autonomous Vehicles As Far Into The Future As He Can Imagine | Elon Musk, CEO of Tesla Inc. (NASDAQ:TSLA), announced that he envisions Tesla having the largest fleet of autonomous veh | [Link](https://longbridge.com/zh-HK/news/276007509.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。